NIBRT Attending Bioprocess International in Boston 27th – 30th September 2022

NIBRT is delighted to be participating in, and an associate sponsor of,  Bioprocess International in Boston 

Date and Location: 27-30th September, 2022 | Boston Convention and Exhibition Centre

NIBRT Booth 423: Meet Killian O’Driscoll –  Chief Operating Officer NIBRT and Barry Shortt –  Business Development Manager NIBRT

NIBRT Speakers: Colin Clarke –  Principal Investigator NIBRT and Michael Butler – Principal Investigator NIBRT

Make an Appointment to Meet NIBRT Team at Event: Click here

 

Bioprocess International is the largest bioprocessing event for learning how to accelerate promising biologics, cell and gene therapies towards commercial success. The NIBRT team look forward to meeting some old friends and new faces and if you are planning to be there please drop by and say hello (booth 423). Also be sure not to miss NIBRT’s speakers at this event – see presentation titles and times below. For anyone that cannot travel to this event there is an option to attend virtually.

If you would like to make an official appointment to meet the NIBRT team at this event please fill out this form and we will be delighted to arrange an appointment with you.

NIBRT Speaker Presentations & Times

Presentation – Sep 28th, 9.00am

Found in translation: Microproteins are a new class of potential host cell impurity in mAb drug products

Mass spectrometry (MS) has emerged as a powerful approach for the detection of Chinese hamster ovary (CHO) cell protein impurities in antibody drug products. The incomplete annotation of the Chinese hamster genome, however, limits the coverage of MS-based analysis. In this study, we performed ribosome footprint profiling (Ribo-seq) to expand annotation of the Chinese hamster proteome and subsequently identified host cell proteins as a potential source of process related impurities in antibody drug product.

Presentation – Sep 28th, 1.30pm

Use of Capacitance and High Resolution Optical Measurements as a Way of Continuous Monitoring of a Bioprocess